These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36190296)

  • 1. Construction of Cyclic Cell-Penetrating Peptides for Enhanced Penetration of Biological Barriers.
    Fang D; Wang R; Yu X; Tian Y
    J Vis Exp; 2022 Sep; (187):. PubMed ID: 36190296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stapling of short cell-penetrating peptides for enhanced tumor cell-and-tissue dual-penetration.
    Shi M; Jiang Z; Xiao Y; Song Y; Tang R; Zhang L; Huang J; Tian Y; Zhou S
    Chem Commun (Camb); 2022 Feb; 58(14):2299-2302. PubMed ID: 35075473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic Cell-Penetrating Peptides as Efficient Intracellular Drug Delivery Tools.
    Park SE; Sajid MI; Parang K; Tiwari RK
    Mol Pharm; 2019 Sep; 16(9):3727-3743. PubMed ID: 31329448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in cell penetrating peptides and their functionalization of polymeric nanoplatforms for drug delivery.
    Tian Y; Zhou S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Mar; 13(2):e1668. PubMed ID: 32929866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of amphipathic and cationic cyclic cell-penetrating peptides: Significant therapeutic delivery tool.
    Sajid MI; Moazzam M; Stueber R; Park SE; Cho Y; Malik NUA; Tiwari RK
    Peptides; 2021 Jul; 141():170542. PubMed ID: 33794283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cell-penetrating peptides in potential anti-cancer therapy.
    Zhou M; Zou X; Cheng K; Zhong S; Su Y; Wu T; Tao Y; Cong L; Yan B; Jiang Y
    Clin Transl Med; 2022 May; 12(5):e822. PubMed ID: 35593206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-penetrating peptide: a means of breaking through the physiological barriers of different tissues and organs.
    Xu J; Khan AR; Fu M; Wang R; Ji J; Zhai G
    J Control Release; 2019 Sep; 309():106-124. PubMed ID: 31323244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-penetrating, amphipathic cyclic peptoids as molecular transporters for cargo delivery.
    Kim HS; Lee Y; Shin MH; Lim HS
    Chem Commun (Camb); 2021 Jul; 57(55):6800-6803. PubMed ID: 34236370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid Cyclic-Linear Cell-Penetrating Peptides Containing Alternative Positively Charged and Hydrophobic Residues as Molecular Transporters.
    Khayyatnejad Shoushtari S; Zoghebi K; Sajid MI; Tiwari RK; Parang K
    Mol Pharm; 2021 Oct; 18(10):3909-3919. PubMed ID: 34491768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deepened cellular/subcellular interface penetration and enhanced antitumor efficacy of cyclic peptidic ligand-decorated accelerating active targeted nanomedicines.
    Shi NQ; Li Y; Zhang Y; Li ZQ; Qi XR
    Int J Nanomedicine; 2018; 13():5537-5559. PubMed ID: 30271146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New generation of cell-penetrating peptides: Functionality and potential clinical application.
    Reissmann S; Filatova MP
    J Pept Sci; 2021 May; 27(5):e3300. PubMed ID: 33615648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and Mechanism of Highly Efficient Cyclic Cell-Penetrating Peptides.
    Qian Z; Martyna A; Hard RL; Wang J; Appiah-Kubi G; Coss C; Phelps MA; Rossman JS; Pei D
    Biochemistry; 2016 May; 55(18):2601-12. PubMed ID: 27089101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designing Cell-Permeable Macrocyclic Peptides.
    Appiah Kubi G; Dougherty PG; Pei D
    Methods Mol Biol; 2019; 2001():41-59. PubMed ID: 31134566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rational design of cell-penetrating peptides for application in delivery systems.
    Kang Z; Ding G; Meng Z; Meng Q
    Peptides; 2019 Nov; 121():170149. PubMed ID: 31491454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-penetrating Peptides for Cancer-targeting Therapy and Imaging.
    Wang W; Abbad S; Zhang Z; Wang S; Zhou J; Lv H
    Curr Cancer Drug Targets; 2015; 15(4):337-51. PubMed ID: 25669720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved Intracellular Delivery of Polyarginine Peptides with Cargoes.
    Hu J; Lou Y; Wu F
    J Phys Chem B; 2019 Mar; 123(12):2636-2644. PubMed ID: 30830784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Delivery Strategies to Improve the Target of Cell Penetrating Peptides Used for Tumor-Related Therapeutics.
    Zhang F; Yang D; Jiang S; Wu L; Qin L; He H; Zhang P
    Curr Pharm Des; 2018; 24(5):541-548. PubMed ID: 28758600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenge to overcome current limitations of cell-penetrating peptides.
    Kim GC; Cheon DH; Lee Y
    Biochim Biophys Acta Proteins Proteom; 2021 Apr; 1869(4):140604. PubMed ID: 33453413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-Penetrating Peptides: Design Strategies beyond Primary Structure and Amphipathicity.
    Kalafatovic D; Giralt E
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29117144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Cyclic, Cell Penetrating Peptide Compatible with In Vitro Selection Strategies.
    Abrigo NA; Dods KK; Makovsky CA; Lohan S; Mitra K; Newcomb KM; Le A; Hartman MCT
    ACS Chem Biol; 2023 Apr; 18(4):746-755. PubMed ID: 36920103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.